Ross Muken

Ross Muken

Chief Executive Officer at SOPHIA GENETICS SA

Net worth: 5 M $ as of 30/06/2026

46 year
Finance
Technology Services
Consumer Services

Profile

Ross Muken is President, Chief Executive Officer & Director at SOPHiA GENETICS SA since 2026.
Former roles include Managing Director-Equity Research at Thomas Weisel Partners LLC, Senior Managing Director at Evercore Group LLC from 2012 to 2019, Research Analyst at Deutsche Bank Securities, Inc. from 2005 to 2012, Partner-Equity Research at International Strategy & Investment Group LLC from 2012 to 2019, Chief Operating & Financial Officer at Click Therapeutics, Inc. from 2019 to 2020, and Principal at Banc of America Securities LLC.
Education includes undergraduate studies at Boston University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
06/07/2026 8,70,651 ( 1.06% ) 5 M $ 30/06/2026

Ross Muken active positions

CompaniesPositionStart
SOPHIA GENETICS SA Chief Executive Officer 01/07/2026

Former positions of Ross Muken

CompaniesPositionEnd
Director of Finance/CFO 01/01/2020
Analyst-Equity 01/09/2019
Analyst-Equity 01/12/2015
Analyst-Equity 30/06/2012
Analyst-Equity 30/06/2005
See the detail of Ross Muken's experience

Training of Ross Muken

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

93

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Finance

Finance

Technology Services

Consumer Services

Finance

Finance

Finance

Technology Services